President Donald Trump has warned a group of major U.S. drugmakers that his administration is set to impose tariffs on ...

Merck shares have been under pressure amid disappointing sales trends for its Gardasil HPV vaccine. The company's broader ...

Shares of Merck & Co. Inc. MRK rallied 2.08% to $89.50 Friday, on what proved to be an all-around rough trading session for ...

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of ...

SharkNinja, a maker of kitchen and household appliances, beat estimates for Q4 and with its guidance. SharkNinja stock rose.

Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the fourth quarter and fiscal year of 2024, provided an update on progress toward achieving key ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE ... leading to lower AI data center capital expenditure and lower demand for its products. Since the selloff though, the ...

On Tuesday, Merck & Co Inc (NYSE:MRK) reported fourth-quarter sales of $15.62 billion, up 7% year over year and slightly beating the consensus estimate of $15.49 billion. Excluding the impact of ...

Product safety, measuring the health effects of exposure to chemicals and chemical contaminants in food.

Investors hammered Merck stock Tuesday after the company beat fourth-quarter expectations, but delivered a light 2025 outlook.